Symposia: Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders
Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Artificial intelligence (AI), Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, Hodgkin lymphoma, Combination therapy, AML, MDS, Fundamental Science, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Bispecific Antibody Therapy, Lymphomas, CLL, Non-Hodgkin lymphoma, APL, Translational Research, Epidemiology, Elderly, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Chemotherapy, B Cell lymphoma, CML, Clinical Research, Health outcomes research, Diversity, Equity, and Inclusion (DEI), T Cell lymphoma, Chronic Myeloid Malignancies, Health disparities research, Pediatric, Education, Supportive Care, Diseases, Indolent lymphoma, Patient-reported outcomes, Treatment Considerations, Biological therapies, Aggressive lymphoma, Real-world evidence, Adverse Events, Lymphoid Malignancies, Non-Biological therapies, Metabolism, Registries, Young adult , Biological Processes, Myeloid Malignancies, Emerging technologies, Survivorship, Technology and Procedures, Study Population, Human
Type: Poster
Hematology Disease Topics & Pathways:
Research, Artificial intelligence (AI), Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, Hodgkin lymphoma, Combination therapy, AML, MDS, Fundamental Science, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Bispecific Antibody Therapy, Lymphomas, CLL, Non-Hodgkin lymphoma, APL, Translational Research, Epidemiology, Elderly, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Chemotherapy, B Cell lymphoma, CML, Clinical Research, Health outcomes research, Diversity, Equity, and Inclusion (DEI), T Cell lymphoma, Chronic Myeloid Malignancies, Health disparities research, Pediatric, Education, Supportive Care, Diseases, Indolent lymphoma, Patient-reported outcomes, Treatment Considerations, Biological therapies, Aggressive lymphoma, Real-world evidence, Adverse Events, Lymphoid Malignancies, Non-Biological therapies, Metabolism, Registries, Young adult , Biological Processes, Myeloid Malignancies, Emerging technologies, Survivorship, Technology and Procedures, Study Population, Human
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H
(San Diego Convention Center)
See more of: Oral and Poster Abstracts
*signifies non-member of ASH